Clinical trial
Evaluation of STARgraft-3 for Hemodialysis
NCT05729620 is registered in ClinicalTrials.gov with Healionics Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of STARgraft-3 for Hemodialysis
- Lead sponsor
- Healionics Corporation
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- November 29, 2022
- Completion date
- July 31, 2027
- Enrollment
- 21 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease